Missing Cirrhosis on CT Scan

Slides:

Advertisements

Similar presentations

Diabetes Mellitus and Non- Alcoholic Fatty Liver Diseas

Advertisements

Dr. David Pearson Gastroenterology, Victoria.  None relevant to this presentation.

Case Presentations: Genes and Liver Disease Victor Ankoma-Sey, MD Director, Liver Transplant Program, Houston Methodist Hospital Director, Liver Associates.

Update in Liver Disease SGNA April 4, 2014 Outline Interpretation of elevated liver chemistries Fatty liver disease Hepatitis B Hepatitis C.

LIVER PATHOLOGY LAB MHD II January 20, Case 1 Describe the low power findings.

The Liver. Function: –Metabolism Anatomy/Histology –Right, left lobe –Biliary Tree –Components of Liver: 1. Liver Parenchyma (lobule) 2. Portal area (vessels,

Ontario College of Family Physicians 51 st Annual Scientific Assembly Barry Lumb Fatty Liver Disease.

NYU Medical Grand Rounds Clinical Vignette Jeffrey Mayne, MD Third Year Resident Internal Medicine 1/17/2012 U NITED S TATES D EPARTMENT OF V ETERANS A.

 Fatty liver disease can range from fatty liver alone (steatosis) to fatty liver associated with inflammation (steatohepatitis). This condition can occur.

Deranged LFTs Pathways A H Mohsen Dr A H Mohsen MD (KCL), MRCP, DTM&H Consultant Gastroenterologist.

An Approach to Abnormal LFTs Robert C. Lowe, M.D. Boston Medical Center July 17, 2013.

Department of Medicine Grand Rounds Clinical Vignette Ilana Bragin January 14 th, 2009 NYU Langone Medical Center Internal Medicine Residency Program.

CIRRHOSIS OF LIVER PORTAL HYPERTENSION HEPATIC ENCHEPALOPATHY

Cholestatic Liver Disease Primary Biliary Cirrhosis.

NYU Medical Grand Rounds Clinical Vignette Joseph Shin MD, PGY-2 March 31, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Department of Medicine Grand Rounds Clinical Vignette Wednesday, March 4, 2009 Peter Shue, M.D.

Cirrhoses And Its Complications Ahmad Shavakhi.

BSG Pathology Section Liver Slide Seminar, Birmingham, March Clinical Summaries - Stefan Hübscher Prof. Stefan Hubscher Case 1 Male, age 52. Recent.

SYB Case #2 Jordan Torok Class of 2010 December 11 th, 2008.

CIRRHOSISPathophysiology&Complications. Normal liver functions Carbohydrate Metabolism Hypo- or hyperglycemia Fatty Acids Metabolism Lipid Transport.

Evaluation of Abnormal Liver Tests

Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.

경희대학교병원 간암 다학제증례집담회 Multidisciplinary case conference Liver Cancer Conference 소화기 센터 회의실

경희대학교병원 간암 다학제증례집담회 Multidisciplinary case conference Liver Cancer Conference 소화기 센터 회의실

경희대학교병원 간암 다학제증례집담회 Multidisciplinary case conference Liver Cancer Conference 소화기 센터 회의실

Evaluation of Abnormal LFT's Vinod Kurup, MD July 28, 2003 CC-BY-SA.

경희대학교병원 간암 다학제증례집담회 Multidisciplinary case conference Liver Cancer Conference 소화기 센터 회의실

Intern Report Patient Presentation  55yM no PMH presenting with worsening abdominal pain for 2-3 days. Describes pain as diffuse, non-radiation,

Benign Liver Masses in HIV Patient

Approach to Ascites Updated by Daniel Kim, 06/2017.

Recurrent hepatitis with Halogenated Anesthetics

Liver Disease tutoring Part 1

AN INTERESTING CAUSE FOR CHRONIC LIVER DISEASE

Drug Induced Hepatitis Progressing to Cirrhosis

History 24 Year old woman 6 Months of age “severe cholangitis’’ emergently decompressed via cholecystostomy tube choledochal cyst noted Definitive surgery:

Progressive Liver Failure following Gastric Bypass

Guidelines for the diagnosis and management of Nonalcoholic Fatty Liver Disease (NAFLD): Update in 2012 Sameh M Fakhry MD, Msc, PhD Consultant of Gastroenterology,

Acute hepatitis of uncertain cause, rule out EBV related

Underwriting Screening Liver Test Abnormalities:

Hemangioendothelioma

Primary biliary cirrhosis, cirrhotic stage

Chronic viral hepatitis type B with “ground glass” cells

Chapter 13 Hepatic Tumors, Benign 1

Successful TACE for HCC

Drug Induced Ductopenia

Wilson’s Disease.

Alcoholic cirrhosis and acute alcoholic fatty liver with cholestasis

Recurrent Hepatitis C Post OLT for HCC and Cirrhosis

Typical Case of HCC.

Non-alcoholic steatohepatitis with positive ANA

Chapter 14 Hepatic Tumors, Malignant 1

Orthotopic liver transplant, recurrent non-alcoholic steatohepatitis

Comorbidity NASH/HCV and HCC

Alcoholic foamy degeneration with early alcoholic cirrhosis

Successful TACE followed by OLT for HCC in Alcoholic Cirrhosis

Acute viral hepatitis type C

Successful Tace in Patient with large HCC

AFP > 9000 without demonstrable HCC

Chapter 12 Liver Transplantation 1

Chapter 3 Fatty Liver Diseases 1 Alcoholic steatosis Case 3.1.

History 56 y/o male from Cuba newly diagnosed with hepatitis C genotype 2b in Jan 2008 No symptoms of decompensation.

Alcoholic hepatitis with diffuse interstitial fibrosis

Giant Hemangiomas.

Primary biliary cirrhosis, AMA negative

NAFLD Paul Trembling Consultant Hepatologist

Presentation transcript:

Missing Cirrhosis on CT Scan

History 33 year old male referred for cirrhosis and liver masses Abnormal LFT’s since 1992 PMH of DM, HTN, dyslipidemia and migraine No alcohol and quit smoking Home meds – pioglitazone, metformin, ursodiol, olmesartan, liothyronine, insulin

Exam Vitals stable, BMI of 39 Alert and oriented No icterus Enlarged liver and spleen No ascites or edema

Laboratory Data Hemoglobin 15.1 WBC 6.1 Platelets 134 INR 1.0 AST 41, ALT 50 Alk phosphatase 83 T. Bilirubin 0.6 Albumin – 4.5 INR – 1.0 MELD score of 6 ANA, AMA, AMA M2, ASMA, ceruloplasmin, Cu, ferritin and hepatitis panel – negative Alpha1-AT level normal and phenotype MM

MRI 9/28/07 Nodules 3x4 cm and 3x2.5 cm

Nodules 3x4 cm and 3x2 cm MRI 12/28/07

MRI 6/23/08

Summary Outside MRI – nodules in the right lobe 9/07 – 3x4 cm and 3x2.5 cm 12/07 – 3x4 cm and 3.5x2cm 6/08 – 4.7x3.9 cm and 4.5x3.2cm Repeat CT and MRI (10/08) – no masses AFP 4 (11/07)  3 (6/08)  3.4 (10/08)

Follow-up triple phase CT (10/22/08)

Follow-up triple phase CT (1/16/09)

Work Up NO varices on EGD Etiology is NASH related cirrhosis Diagnostic laparoscopy

Pathology Liver biopsy in 10/07 – cirrhosis with moderate fatty degeneration and mild nonspecific portal inflammation with bile ductular proliferation Liver biopsy in 10/08 – cirrhosis with mild steatosis (30%), glycogenated nuclei, and chronic inflammation (from the nodule)